Arevalo and Pavic enter the Montreal semifinal as the third seeds with a strong recent record, including a title at Queen's Club and a dominant quarterfinal win over the home Canadian pair. The experienced duo combines Arévalo's Grand Slam pedigree with Pavic's consistent net play and serving on hard courts. Arribage and Olivetti have shown impressive form this season, securing multiple ATP titles and advancing through the draw after victories over Bhambri/Venus and a rain-delayed quarterfinal against Medvedev/Marozsan. Their aggressive baseline game and recent momentum create a competitive matchup, though the higher-ranked pair holds the edge in head-to-head experience at Masters level. Surface conditions and any late lineup adjustments remain key variables.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoArevalo/Pavic – Arribage/Olivetti
Moneyline
$0 Vol.
This market will resolve to 'Arevalo/Pavic' if the team of Arevalo/Pavic advances against Arribage/Olivetti.
This market will resolve to 'Arribage/Olivetti' if the team of Arribage/Olivetti advances against Arevalo/Pavic.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team advances due to the opponent's retirement, default, or disqualification, this market will resolve to the team who advances.
If the match ends in a walkover (a team withdraws before the start and the other advances automatically), this market will resolve to 50-50.
The primary resolution source will be official information from the ATP Tour. A consensus of credible reporting may also be used.
Mercado abierto: Aug 11, 2026, 6:00 PM ET
Fuente de resolución
https://www.atptour.com/en/scores/currentResolver
0x65070BE91...Arevalo/Pavic – Arribage/Olivetti
Moneyline
$0 Vol.
This market will resolve to 'Arevalo/Pavic' if the team of Arevalo/Pavic advances against Arribage/Olivetti.
This market will resolve to 'Arribage/Olivetti' if the team of Arribage/Olivetti advances against Arevalo/Pavic.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team advances due to the opponent's retirement, default, or disqualification, this market will resolve to the team who advances.
If the match ends in a walkover (a team withdraws before the start and the other advances automatically), this market will resolve to 50-50.
The primary resolution source will be official information from the ATP Tour. A consensus of credible reporting may also be used.
Mercado abierto: Aug 11, 2026, 6:00 PM ET
Fuente de resolución
https://www.atptour.com/en/scores/currentResolver
0x65070BE91...Arevalo and Pavic enter the Montreal semifinal as the third seeds with a strong recent record, including a title at Queen's Club and a dominant quarterfinal win over the home Canadian pair. The experienced duo combines Arévalo's Grand Slam pedigree with Pavic's consistent net play and serving on hard courts. Arribage and Olivetti have shown impressive form this season, securing multiple ATP titles and advancing through the draw after victories over Bhambri/Venus and a rain-delayed quarterfinal against Medvedev/Marozsan. Their aggressive baseline game and recent momentum create a competitive matchup, though the higher-ranked pair holds the edge in head-to-head experience at Masters level. Surface conditions and any late lineup adjustments remain key variables.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoCuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes
Crear un combo
Elige dos opciones
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes